Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain-containing protein 6 (ANKRD6) is a cytosolic scaffolding protein composed of 6 ankyrin repeats, encoded by the ANKRD6 gene (aliases: Diversin, KIAA0957, Diego homolog). It plays a regulatory role in the negative control of canonical Wnt/β-catenin signaling by recruiting casein kinase I epsilon to the β-catenin degradation complex, thereby facilitating phosphorylation and inhibition of β-catenin signaling. ANKRD6 is prominently expressed in the developing mammalian brain and is also involved in planar cell polarity, interacting with core components of the PCP pathway, notably in the inner ear for cellular orientation and sensory function. As the mammalian homolog of Drosophila diego, ANKRD6 is important for developmental processes but is not currently considered a direct receptor, enzyme, or therapeutic target for drug intervention. No disease-associated pathogenic mutations or actionable pharmacological interventions are reported, though variants may associate with certain inherited disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain-containing protein 6 (ANKRD6).